CNSYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
CERENOME, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.65−0.05 (-2.94%)
Close on Oct 19, 2026
- Market cap
- $11.38M
- P/E (TTM)
- –
- Dividend yield
- –
CERENOME, INC. revenue by segment
By business segment
By product or service
| Revenue | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | Q1 23 | Q4 22 | Q3 22 | Q1 19 | Q4 18 | Q3 18 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grant [Member] | $1.46M | $1.28M | $1.68M | $1.31M | $1.24M | $1.85M | $506.00K | $151.00K | $73.00K | – | – | – | 100.0% | +17.4% |
| Consumable [Member] | – | – | – | – | – | – | – | – | – | $663.00K | $324.00K | $692.00K | – | – |
| Device [Member] | – | – | – | – | – | – | – | – | – | – | $31.00K | $101.00K | – | – |
| Other Products [Member] | – | – | – | – | – | – | – | – | – | $40.00K | $67.00K | $65.00K | – | – |
| Product revenue [Member] | – | – | – | – | – | – | – | – | – | $703.00K | – | – | – | – |
| Government Contracts and Other [Member] | – | – | – | – | – | $1.85M | – | – | – | – | – | – | – | – |
By region
| Revenue | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | Q1 23 | Q4 22 | Q3 22 | Q1 19 | Q4 18 | Q3 18 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Japan | – | – | – | – | – | – | – | – | – | $419.00K | $365.00K | $535.00K | – | – |
| Americas [Member] | – | – | – | – | – | – | – | – | – | $64.00K | $44.00K | $199.00K | – | – |
| Asia Pacific [Member] | – | – | – | – | – | – | – | – | – | $70.00K | $5.00K | $10.00K | – | – |
| EMEA [Member] | – | – | – | – | – | – | – | – | – | $150.00K | $8.00K | $114.00K | – | – |
From the segment and revenue-disaggregation notes of Cerenome's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.